ada.enesco, Author at European Medical Journal - Page 6 of 27

Managing Factor Xa Inhibitors Perioperatively: PERIXa Shows Promise

New study finds the PERIXa protocol for perioperative anticoagulation in AF patients undergoing low-risk procedures is safe.

Exploring Bladder Preservation in Muscle-Invasive Bladder Cancer Treatment

The combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible and safe treatment strategy.

Early Lung Function Decline Predicts Long-Term Respiratory Symptoms

Individuals with impaired lung function trajectories experience a higher burden of respiratory symptoms, including wheeze and phlegm.

New Evidence Supports PPI Co-Prescription in Patients with AMI Undergoing PCI

PPIs significantly reduce gastrointestinal bleeding risk in AMI patients on DAPT without increasing cardiovascular events. Read more on clinical implications.

High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma

Multiple myeloma patients with two or more high-risk genetic abnormalities face significantly poorer outcomes, regardless of disease stage or treatment.

Study Shows Primary Care and Telehealth Can Provide Effective Diabetes Care

People with Type 1 diabetes can achieve the same positive outcomes using advanced insulin technology when trained by their PCPs or through telehealth as they would by visiting a specialist in person according to new study.

Evaluating Dupilumab for Peanut Allergy Desensitisation in Children

A proof-of-concept study was conducted to explore whether dupilumab could induce desensitisation to peanut in children with peanut allergy.

Rencofilstat Improves Liver Function in Patients with MASH

The study suggests that rencofilstat 225mg/d improves both liver function and portal-systemic shunting in patients with MASH.

Tetramethylpyrazine Nitrone Benefits Grip Strength in Younger Patients with ALS

A clinical trial finds tetramethylpyrazine nitrone safe for ALS, with potential benefits in grip strength for younger patients.

Anti-obesity Medications Help Prevent Joint Replacement Failures

New research suggests that patients with obesity who undergo knee or hip replacements can lower their risk of revision surgery by losing weight after the procedure with anti-obesity medications.